New Daily Oral GLP-1 Drug Approved for Weight Loss and Diabetes
The FDA approved orforglipron, a once-daily pill that works like Ozempic and Wegovy but doesn't require injections. The oral medication helps people lose 5-10% of their body weight and lowers blood sugar levels without fasting requirements.
CONTINUE READING ▸
Major Changes Coming to GLP-1 Drug Market and Coverage
The GLP-1 medication market is seeing significant changes, including FDA approval of oral weight loss drugs and expanded Medicare coverage starting in July 2024. These shifts could make weight loss medications more accessible to patients.
CONTINUE READING ▸
Compounding Pharmacies Challenge Big Pharma GLP-1 Drug Sales
The growing peptide market is creating competition for brand-name GLP-1 drugs as compounding pharmacies offer alternatives to expensive medications. This trend is causing tension between commercial drug companies and compounding pharmacies over patient access to weight loss treatments.
CONTINUE READING ▸
Eli Lilly Reports Positive Results for Oral GLP-1 Drug
Eli Lilly announced promising test results for its oral GLP-1 medication, adding to positive news about pill-form weight loss drugs. The company is working to develop alternatives to injectable medications that could reach more patients.
CONTINUE READING ▸
GLP-1 Drug Market Expected to Grow Despite High Costs
The market for GLP-1 medications is expected to expand through 2034, driven by rising diabetes cases and new drug delivery methods. However, high costs and regulatory challenges remain barriers to wider patient access.
CONTINUE READING ▸
Regular Foods Can’t Match GLP-1 Drugs for Appetite Control
Natural GLP-1 hormone levels from eating regular foods have little effect on appetite or weight loss, according to researchers. The much higher hormone levels achieved through medications like Ozempic are what actually reduce hunger and help with weight loss.
CONTINUE READING ▸
GLP-1 Weight Loss Drugs May Affect Mental Health and Mood
Some patients taking GLP-1 medications for weight loss report experiencing less pleasure and excitement in their daily lives. This potential mental health side effect is raising concerns among doctors and patients about the emotional impact of these popular weight loss drugs.
CONTINUE READING ▸
Some GLP-1 Users Report Feeling Less Joy and Excitement
Some people taking GLP-1 weight loss drugs like Ozempic and Wegovy say they feel less pleasure and excitement in daily life. Doctors confirm these emotional changes are real side effects, not imagined, and advise patients to seek help if they experience reduced joy.
CONTINUE READING ▸
Most Employer Health Plans Don’t Cover GLP-1 Weight Loss Drugs
About 80% of employer health plans don't cover GLP-1 medications like Wegovy for weight loss, though some companies are adding coverage hoping it will reduce long-term healthcare costs. Only about 20% of employers currently offer this benefit to their workers.
CONTINUE READING ▸
Local Investigation Explores Benefits and Risks of GLP-1 Weight Loss Drugs
A local news investigation examines the benefits and potential risks of popular GLP-1 medications like Ozempic and Wegovy, featuring patient experiences including one woman who has used the treatment for two years.
CONTINUE READING ▸
Woman Loses 105 Pounds Using GLP-1 Drug Tirzepatide
Amber achieved dramatic weight loss of 105 pounds using tirzepatide, a GLP-1 medication similar to Ozempic. Her transformation story includes details about the weight loss process and additional aesthetic treatments she received.
CONTINUE READING ▸
New Study Questions Whether GLP-1 Drugs Actually Cause Muscle Loss
A new study challenges concerns that popular weight-loss drugs like Ozempic and Wegovy cause significant muscle loss. Researchers found that much of the tissue loss previously attributed to muscle may actually come from healthier reductions in liver fat and other non-muscle tissue.
CONTINUE READING ▸
Amazon Pharmacy Now Offers Ozempic Pills for Weight Loss
Amazon is expanding its pharmacy services by adding Novo Nordisk's oral version of Ozempic to its platform. This move positions Amazon to capture more of the growing market for GLP-1 weight loss medications.
CONTINUE READING ▸
New Study Shows GLP-1 Weight Loss Drugs May Preserve More Muscle Than Expected
Previous research suggested that popular weight loss drugs like Wegovy and Zepbound caused people to lose too much muscle along with fat. A new study challenges this concern, finding that muscle mass loss may not be as severe as scientists initially thought.
CONTINUE READING ▸
Scientists Discover Why Weight Loss Drugs Don’t Work for Some People
New genetic research identified a specific gene variant that makes some people less responsive to GLP-1 weight loss drugs. People with this genetic variation may need different medications because their bodies don't process the GLP-1 hormone effectively.
CONTINUE READING ▸
Doctor Says Prescribing Weight Loss Drugs to Kids Shows We Failed Them
A pediatric obesity researcher who studies GLP-1 weight loss drugs in children argues that needing to prescribe these medications to kids indicates broader societal failures. The opinion piece suggests we should have prevented childhood obesity rather than treating it with daily injections.
CONTINUE READING ▸
FDA proposes permanent ban on compounded GLP-1 weight loss drugs
The FDA is proposing new rules that would permanently prevent specialty pharmacies from making their own versions of popular GLP-1 drugs like semaglutide and tirzepatide.
CONTINUE READING ▸
New Study Shows GLP-1 Drugs May Protect Against Alzheimers
A new study suggests GLP-1 medications may reduce levels of amyloid-beta and tau proteins linked to Alzheimer's disease. This potential brain-protective benefit could change how we think about these drugs beyond their weight loss effects.
CONTINUE READING ▸
How Bone Broth Can Help GLP-1 Users Manage Side Effects
Bone broth provides lean protein, essential electrolytes, and hydration that can help GLP-1 users manage side effects and preserve muscle mass during weight loss. This nutrient-rich food fits well into the dietary needs of people taking these medications.
CONTINUE READING ▸
New oral weight loss pill shows promise but may have more side effects
Orforglipron, a new pill-form GLP-1 drug, performed better than oral semaglutide in clinical trials for blood sugar control and weight loss. However, the medication may cause more side effects than current options, and it's easier to manufacture and store than existing treatments.
CONTINUE READING ▸